Vanguard Personalized Indexing Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Buy |
13,390
+4,302
| +47% | +$1.4M | 0.05% | 331 |
|
|
2025
Q1 | $2.45M | Buy |
9,088
+514
| +6% | +$139K | 0.04% | 422 |
|
|
2024
Q4 | $2.02M | Sell |
8,574
-404
| -4% | -$95.1K | 0.03% | 477 |
|
|
2024
Q3 | $2.47M | Buy |
8,978
+1,825
| +26% | +$502K | 0.04% | 397 |
|
|
2024
Q2 | $1.74M | Buy |
7,153
+1,067
| +18% | +$259K | 0.03% | 454 |
|
|
2024
Q1 | $910K | Sell |
6,086
-304
| -5% | -$45.4K | 0.02% | 711 |
|
|
2023
Q4 | $1.22M | Buy |
6,390
+655
| +11% | +$125K | 0.03% | 534 |
|
|
2023
Q3 | $1.02M | Sell |
5,735
-623
| -10% | -$110K | 0.03% | 552 |
|
|
2023
Q2 | $1.21M | Buy |
6,358
+59
| +0.9% | +$11.2K | 0.04% | 480 |
|
|
2023
Q1 | $1.26M | Sell |
6,299
-293
| -4% | -$58.7K | 0.04% | 429 |
|
|
2022
Q4 | $1.57M | Buy |
6,592
+726
| +12% | +$173K | 0.06% | 340 |
|
|
2022
Q3 | $1.17M | Buy |
5,866
+1,398
| +31% | +$280K | 0.05% | 411 |
|
|
2022
Q2 | $652K | Buy |
4,468
+275
| +7% | +$40.1K | 0.03% | 684 |
|
|
2022
Q1 | $685K | Buy |
4,193
+1,304
| +45% | +$213K | 0.03% | 661 |
|
|
2021
Q4 | $490K | Buy |
2,889
+438
| +18% | +$74.3K | 0.03% | 707 |
|
|
2021
Q3 | $463K | Buy |
2,451
+222
| +10% | +$41.9K | 0.04% | 553 |
|
|
2021
Q2 | $378K | Buy |
+2,229
| New | +$378K | 0.04% | 626 |
|